First American Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $556K | Sell |
23,110
-67
| -0.3% | -$1.75K | 0.03% | 168 |
|
|
2026
Q1 | $651K | Buy |
23,177
+352
| +2% | +$9.37K | 0.04% | 151 |
|
|
2025
Q4 | $568K | Buy |
22,825
+79
| +0.3% | +$1.99K | 0.03% | 152 |
|
|
2025
Q3 | $580K | Buy |
22,746
+700
| +3% | +$17.3K | 0.04% | 150 |
|
|
2025
Q2 | $534K | Hold |
22,046
| – | – | 0.04% | 145 |
|
|
2025
Q1 | $559K | Sell |
22,046
-600
| -3% | -$15.7K | 0.04% | 140 |
|
|
2024
Q4 | $601K | Buy |
22,646
+274
| +1% | +$7.43K | 0.04% | 139 |
|
|
2024
Q3 | $647K | Buy |
22,372
+13
| +0.1% | +$379 | 0.05% | 138 |
|
|
2024
Q2 | $626K | Buy |
22,359
+689
| +3% | +$19K | 0.05% | 134 |
|
|
2024
Q1 | $601K | Sell |
21,670
-741
| -3% | -$20.6K | 0.05% | 138 |
|
|
2023
Q4 | $645K | Sell |
22,411
-1,541
| -6% | -$46.6K | 0.05% | 137 |
|
|
2023
Q3 | $794K | Sell |
23,952
-207
| -0.9% | -$7.32K | 0.07% | 132 |
|
|
2023
Q2 | $886K | Sell |
24,159
-685
| -3% | -$26.7K | 0.08% | 130 |
|
|
2023
Q1 | $1.01M | Sell |
24,844
-2,782
| -10% | -$120K | 0.09% | 125 |
|
|
2022
Q4 | $1.42M | Buy |
27,626
+970
| +4% | +$46.5K | 0.14% | 108 |
|
|
2022
Q3 | $1.17M | Buy |
26,656
+417
| +2% | +$20.3K | 0.12% | 110 |
|
|
2022
Q2 | $1.38M | Hold |
26,239
| – | – | 0.14% | 108 |
|
|
2022
Q1 | $1.36M | Hold |
26,239
| – | – | 0.12% | 118 |
|
|
2021
Q4 | $1.55M | Sell |
26,239
-530
| -2% | -$26.3K | 0.08% | 157 |
|
|
2021
Q3 | $1.15M | Sell |
26,769
-1,076
| -4% | -$47.7K | 0.07% | 171 |
|
|
2021
Q2 | $1.09M | Sell |
27,845
-67,879
| -71% | -$2.64M | 0.06% | 183 |
|
|
2021
Q1 | $3.47M | Sell |
95,724
-37,143
| -28% | -$1.32M | 0.22% | 100 |
|
|
2020
Q4 | $4.89M | Sell |
132,867
-61,171
| -32% | -$2.24M | 0.33% | 76 |
|
|
2020
Q3 | $6.76M | Sell |
194,038
-2,962
| -2% | -$104K | 0.4% | 68 |
|
|
2020
Q2 | $6.11M | Buy |
197,000
+17,212
| +10% | +$585K | 0.39% | 74 |
|
|
2020
Q1 | $5.57M | Buy |
179,788
+4,949
| +3% | +$169K | 0.41% | 78 |
|
|
2019
Q4 | $6.5M | Buy |
+174,839
| New | +$6.23M | 0.41% | 77 |
|
|
2019
Q2 | $7.66M | Sell |
186,307
-718
| -0.4% | -$28.5K | 0.53% | 60 |
|
|
2019
Q1 | $7.54M | Sell |
187,025
-15,672
| -8% | -$628K | 0.54% | 61 |
|
|
2018
Q4 | $8.39M | Buy |
202,697
+10,445
| +5% | +$434K | 0.66% | 46 |
|
|
2018
Q3 | $8.04M | Buy |
+192,252
| New | +$7.4M | 0.55% | 56 |
|
|
2018
Q1 | $6.43M | Buy |
190,930
+2,995
| +2% | +$103K | 0.49% | 62 |
|
|
2017
Q4 | $6.46M | Buy |
187,935
+5,403
| +3% | +$184K | 0.49% | 65 |
|
|
2017
Q3 | $6.18M | Sell |
182,532
-3,858
| -2% | -$124K | 0.47% | 63 |
|
|
2017
Q2 | $5.94M | Sell |
186,390
-18,885
| -9% | -$596K | 0.47% | 63 |
|
|
2017
Q1 | $6.66M | Buy |
205,275
+13,311
| +7% | +$420K | 0.54% | 50 |
|
|
2016
Q4 | $5.92M | Buy |
191,964
+10,610
| +6% | +$324K | 0.5% | 54 |
|
|
2016
Q3 | $5.83M | Buy |
181,354
+13,776
| +8% | +$461K | 0.53% | 43 |
|
|
2016
Q2 | $5.6M | Buy |
167,578
+17,707
| +12% | +$565K | 0.54% | 41 |
|
|
2016
Q1 | $4.21M | Buy |
149,871
+7,744
| +5% | +$221K | 0.42% | 53 |
|
|
2015
Q4 | $4.35M | Buy |
142,127
+5,943
| +4% | +$187K | 0.44% | 51 |
|
|
2015
Q3 | $4.06M | Buy |
136,184
+12,330
| +10% | +$395K | 0.45% | 50 |
|
|
2015
Q2 | $3.94M | Sell |
123,854
-1,402
| -1% | -$45.7K | 0.39% | 58 |
|
|
2015
Q1 | $4.13M | Buy |
125,256
+1,757
| +1% | +$55.9K | 0.41% | 57 |
|
|
2014
Q4 | $3.65M | Buy |
123,499
+779
| +0.6% | +$22.3K | 0.39% | 62 |
|
|
2014
Q3 | $3.44M | Buy |
122,720
+6,008
| +5% | +$169K | 0.37% | 61 |
|
|
2014
Q2 | $3.29M | Buy |
116,712
+2,115
| +2% | +$60.3K | 0.35% | 65 |
|
|
2014
Q1 | $3.49M | Buy |
114,597
+91,783
| +402% | +$2.74M | 0.39% | 59 |
|
|
2013
Q4 | $663K | Buy |
22,814
+264
| +1% | +$7.68K | 0.08% | 103 |
|
|
2013
Q3 | $615K | Hold |
22,550
| – | – | 0.08% | 104 |
|
|
2013
Q2 | $599K | Buy |
+22,550
| New | +$623K | 0.08% | 101 |
|
Other funds holding PFE
AIM
SLAM
CWP
First American Bank's PFE Position: Q2 2026 in Review
First American Bank reduced its Pfizer (PFE) stake by 0.29% in Q2 2026, selling an estimated $1.75K and leaving 23,110 shares worth $556K. The position accounts for 0.03% of the portfolio, ranked #168.
First American Bank first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.39M in Q4 2018. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- First American Bank held 23,110 shares of Pfizer worth $556K as of Q2 2026.
- First American Bank sold 67 Pfizer shares in Q2 2026, an estimated $1.75K.
- Pfizer made up 0.03% of First American Bank's portfolio in Q2 2026, its #168 holding.
- First American Bank first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- First American Bank's Pfizer position peaked at $8.39M in Q4 2018.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.